Fig. 3.
Putative targets for therapeutic intervention in the Hippo pathway. Summary of the positive and negative regulators of Hippo kinases and YAP/TAZ, respectively. Activating components’ upstream of YAP/TAZ is in green, and inhibitory components are in red